PTNS as a Treatment for Tenesmus

Launched by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST · Oct 16, 2014

Keywords

ClinConnect Summary

The aim of the study is to discover if PTNS can be used to reduce the symptoms in those patients with tenesmus due to their pelvic floor disorders. These pelvic floor disorders include rectal cancer in situ, Anterior Resection Syndrome developed after rectal-cancer treatment, or gynaecological problems. Gynaecological problems that can cause tenesmus include radiotherapy for gynaecological cancer, ovarian cysts, pelvic organ prolapse and hysterectomy.

Currently, there is a lack of treatment options available to manage patients with tenesmus and it is hoped that PTNS will provide a simple, ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients that have tenesmus who are post-rectal cancer treatment and have Anterior Resection Syndrome.
• • Patients that have tenesmus who have a rectal cancer.
• • Patients that have tenesmus due to a gynaecological condition.
• Exclusion Criteria:
• • Anyone under the age of 18.
• • Anyone with a pacemaker or implantable defibrillator.
• • Anyone who is prone to excessive bleeding.
• • Anyone who is pregnant or is planning on becoming pregnant throughout their time in the trial.
• • Anyone with diabetic neuropathy, multiple sclerosis, Parkinson's disease or peripheral neuropathy.
• • Inability to provide consent for the research study.
• • Anatomical limitations that would prevent successful placement of needle electrode.
• • Present evidence of external full thickness rectal prolapse.
• • Stoma in situ.